Pluri Inc. — Director's Dealing 2014

Sep 18, 2014

18/9/2014 Submission Proof - \lsbs2011\edgar\EDGAR Filing\Other Filers\Ben-Yoram Israel\Pluristem Therapeutics Inc\1415560\a1415560.gfp

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0287
Expires:	December 31, 2014
Estimated average burden hours per response	0.5
1. Name and Address of Reporting Person* BEN-YORAM ISRAEL 0001320556
---	---
(Last)	(First)
24 BARKAN STREET
(Street)
RISHON LEZION	L3
(City)	(State)
Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
---	---
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)
Common Stock	09/17/2014
Common Stock	09/17/2014
Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security
Code	V

Explanation of Responses:

Remarks:

/s/ Israel Ben-Yoram

09/18/2014

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

file://sbs2011/edgar/EDGAR%20Filing/Other%20Filers/Ben-Yoram%20Israel/Pluristem%20Therapeutics%20Inc/1415560/proof.htm